ANIP - CIK 0001023024
ANI PHARMACEUTICALS INC (ANIP) reported revenue of $883.37M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $883.37M | +43.8% |
| FY 2024 | $614.38M | +26.2% |
| FY 2023 | $486.82M | +53.9% |
| FY 2022 | $316.38M | +46.4% |
| FY 2021 | $216.14M | +3.7% |
| FY 2020 | $208.47M | +0.9% |
| FY 2019 | $206.55M | +2.5% |
| FY 2018 | $201.58M | +14.0% |
| FY 2017 |
ANI PHARMACEUTICALS INC (ANIP) reported revenue of $883.37M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, ANI PHARMACEUTICALS INC's revenue grew from $435.16K to $883.37M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $176.84M |
| +37.5% |
| FY 2016 | $128.62M | +68.5% |
| FY 2015 | $76.32M | +36.4% |
| FY 2014 | $55.97M | +86.1% |
| FY 2013 | $30.08M | +47.7% |
| FY 2012 | $20.37M | +4581.3% |
| FY 2011 | $435.16K | - |